Cargando…

Multiple Evidences for Association between Cognitive Impairment and Dysglycemia in Parkinson’s Disease: Implications for Clinical Practice

Background and purpose: It remains unclear about the etiopathogenesis of cognitive impairment (CI) in Parkinson’s disease (PD). Since diabetes mellitus (DM) has been shown to be associated with CI in several diseases, we examined the association between CI and dysglycemia in PD. Methods: Enrolled PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Liu, Chen, Zhilin, Li, Bo, Wang, Meihua, Yu, Lijia, Wan, Ying, Gan, Jing, Zhang, Yu, Liu, Zhenguo, Wang, Xijin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675878/ https://www.ncbi.nlm.nih.gov/pubmed/29163137 http://dx.doi.org/10.3389/fnagi.2017.00355

Ejemplares similares

Dysglycemia and arrhythmias
por: Sun, Dong-Kun, et al.
Publicado: (2023)

Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson’s disease and roles of microglia, proinflammatory factors, and MAPK
por: Liu, Ying, et al.
Publicado: (2020)

Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease
por: Wan, Ying, et al.
Publicado: (2017)

Brain Structural Alterations, Diabetes Biomarkers, and Cognitive Performance in Older Adults With Dysglycemia
por: Oh, Dae Jong, et al.
Publicado: (2021)

Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A
por: Yu, Lijia, et al.
Publicado: (2017)

Cognitive Changes and Promotion in Parkinson's Disease
por: Wang, XiaoPing, et al.
Publicado: (2018)

Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2021)

Correction to: Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2022)

Behavioral and Neurochemical Deficits in Aging Rats with Increased Neonatal Iron Intake: Silibinin’s Neuroprotection by Maintaining Redox Balance
por: Chen, Hanqing, et al.
Publicado: (2015)

Inhibition of Sirtuin 2 exerts neuroprotection in aging rats with increased neonatal iron intake
por: Wang, Xijin, et al.
Publicado: (2014)

Dysglycemia in the critically ill patient: current evidence and future perspectives
por: Aramendi, Ignacio, et al.
Publicado: (2017)

Impaired myocardial deformation and ventricular vascular coupling in obese adolescents with dysglycemia
por: Brar, Preneet Cheema, et al.
Publicado: (2019)

Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson’s Disease Mice
por: Yan, Aijuan, et al.
Publicado: (2019)

Evidence of Reduced β-Cell Function in Asian Indians With Mild Dysglycemia
por: Staimez, Lisa R., et al.
Publicado: (2013)

Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7
por: Wang, Xijin, et al.
Publicado: (2015)

Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up
por: Pararajasingam, Gokulan, et al.
Publicado: (2019)

Association of In-Hospital Mortality and Dysglycemia in Septic Patients
por: Chao, Hsiao-Yun, et al.
Publicado: (2017)

Dysglycemia and Arthroplasty Outcomes: A Review
por: Alkindy, Talal
Publicado: (2020)

Dysglycemia in Pregnancy and Maternal/Fetal Outcomes
por: Silva, Corinne M., et al.
Publicado: (2021)

Insulin as a Tool in Factitious Dysglycemia
por: Odhaib, Samih A, et al.
Publicado: (2021)

PSUN275 Autoimmune Dysglycemia Syndrome (ADS) Associated with Multiple Rheumatological Conditions
por: Paz-Ibarra, Jose, et al.
Publicado: (2022)

Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome
por: Jarrett, Brittany Y, et al.
Publicado: (2019)

Cognitive impairments in Parkinson's disease: Evidence from an Iranian population
por: Ashrafi, Farzad, et al.
Publicado: (2012)

Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway
por: Yan, Aijuan, et al.
Publicado: (2021)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans
por: Chassaing, Benoit, et al.
Publicado: (2017)

LDL Cholesterol and Dysglycemia: an Intriguing Physiological Relationship
por: Merino, Jordi, et al.
Publicado: (2020)

High PSQI score is associated with the development of dyskinesia in Parkinson’s disease
por: Tang, Xiaohui, et al.
Publicado: (2022)

Assessing impulse control behaviors in early Parkinson’s disease: a longitudinal study
por: Zhu, Xiaobo, et al.
Publicado: (2023)

Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment
por: Canário, Nádia, et al.
Publicado: (2019)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Pan, Chenxi, et al.
Publicado: (2021)

Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment
por: Nie, Kun, et al.
Publicado: (2022)

The correlation between enlarged perivascular spaces and cognitive impairment in Parkinson’s disease and vascular parkinsonism
por: Tu, Yu, et al.
Publicado: (2022)

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2016)

Associations between cognitive impairment and motor dysfunction in Parkinson's disease
por: Wang, Yi‐Xuan, et al.
Publicado: (2017)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Screening for Dysglycemia in Overweight Youth Presenting for Weight Management
por: Morrison, Katherine M., et al.
Publicado: (2012)

Hydrocortisone increases the risk of dysglycemia in critically ill patients
por: Van Hooijdonk, RT, et al.
Publicado: (2012)

Dysglycemia induces abnormal circadian blood pressure variability
por: Kumarasamy, Sivarajan, et al.
Publicado: (2011)

Evaluation of Nonfasting Tests to Screen for Childhood and Adolescent Dysglycemia
por: Lee, Joyce M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eirmt3miideg5qe3q6e5mamtnj